Hongjian Zhang

Dr. Hongjian Zhang


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2019 in Biopharmaceutics & Drug Disposition
Verified
Journal Article
Closed access
PDF file
JKJiehong Kong
Jiehong Kong
YQYajing Qiu
Yajing Qiu
YLYuan Li
Yuan Li
HZHongjian Zhang
Hongjian Zhang
WWWeipeng Wang
Weipeng Wang

12 July 2016 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
YYYuan Yuan
Yuan Yuan
JZJiyue Zheng
Jiyue Zheng
MWMeiyu Wang
Meiyu Wang
YLYuan Li
Yuan Li
JRJianqing Ruan
Jianqing Ruan
HZHongjian Zhang
Hongjian Zhang

28 May 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
YNYao Ni
Yao Ni
ZDZelin Duan
Zelin Duan
DZDandan Zhou
Dandan Zhou
SLShuai Liu
Shuai Liu
HWHuida Wan
Huida Wan
HZHongjian Zhang
Hongjian Zhang
Enalaprilat is the active metabolite of enalapril, a widely used antihypertension drug. The human organic anion transporter 3 (OAT3), which is highly expressed in the kidney, plays a critical role in the renal clearance of many drugs. While urinary excretion is the primary elimination route of enalaprilat, direct involvement of OAT3 has not been reported so far. In the present study, OAT3-mediated uptake of enalaprilat was first characterized, and the inhibition of OAT3 transport activity was then examined for a number of flavonoid and drug molecules with diverse structures. A varying degree of inhibition potency was demonstrated for flavonoids, with IC50 values ranging from 0.03 to 22.6 µM against OAT3 transport activity. In addition, commonly used drugs such as urate transporter 1 (URAT1) inhibitors also displayed potent inhibition on OAT3-mediated enalaprilat uptake. Pharmacophore and three-dimensional quantitative structure-activity relationship (3D-QSAR) analyses revealed the presence of a polar center and a hydrophobic region involved in OAT3-inhibitor binding. For the polar center, hydroxyl groups present in flavonoids could act as either hydrogen bond donors or acceptors and the number and position of hydroxyl groups were critical drivers for inhibition potency, while carboxyl groups present in some drugs could form ionic bridges with OAT3. The predicted inhibition potencies by comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) were correlated well with experimental IC50 values. Taken together, the present study identified OAT3-mediated uptake of enalaprilat as an important mechanism for its renal clearance, which may be liable for drug-drug and herb-drug interactions. The established computational models revealed unique structural features for OAT3 inhibitors and could be used for structure-activity relationship (SAR) analysis of OAT3 inhibition. The clinical relevance of the inhibition of OAT3-mediated enalaprilat uptake warrants further investigation, particularly in populations where herbal remedies and drugs are used concomitantly.

1 December 2015 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
MWMeiyu Wang
Meiyu Wang
HQHuixin Qi
Huixin Qi
JLJiajun Li
Jiajun Li
YXYunting Xu
Yunting Xu
HZHongjian Zhang
Hongjian Zhang

1 May 2020 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
YXYiqun Xiang
Yiqun Xiang
SLShuai Liu
Shuai Liu
JYJingjie Yang
Jingjie Yang
ZWZhongmin Wang
Zhongmin Wang
HZHongjian Zhang
Hongjian Zhang
CGChunshan Gui
Chunshan Gui

9 September 2020 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
JYJingjie Yang
Jingjie Yang
ZWZhongmin Wang
Zhongmin Wang
SLShuai Liu
Shuai Liu
WWWeipeng Wang
Weipeng Wang
HZHongjian Zhang
Hongjian Zhang
CGChunshan Gui
Chunshan Gui